Conference Agenda
| Session | |||||
5.2: In silico trials (Cardiovascular)
| |||||
| Presentations | |||||
12:00pm - 12:12pm
ID: 352 / 5.2: 1 MODELING THE ROLE OF OBESITY IN KIDNEY DISEASE TREATMENT WITH GLP-1 AGONIST University of Mississippi Medical Center, Jackson, MS, United States of America
12:12pm - 12:24pm
ID: 399 / 5.2: 2 IN SILICO COMPARISON OF SUBSTRATE-BASED ABLATION STRATEGIES IN STRUCTURAL VENTRICULAR TACHYCARDIA 1: Research Center E. Piaggio, University of Pisa, Italy; 2: Second Division of Cardiology, Cardio-Thoracic and Vascular Department, Pisa University Hospital; 3: Information Engineering Department, University of Pisa
12:24pm - 12:36pm
ID: 423 / 5.2: 3 IN SILICO EVALUATION OF TRANSCATHETER TRICUSPID VALVE REPLACEMENT WITH THE EVOQUE SYSTEM 1: University of Palermo, Italy; 2: IRCCS ISMETT, Italy
12:36pm - 12:48pm
ID: 636 / 5.2: 4 EFFICIENT TRANSIENT 0D MICROVASCULAR HEMODYNAMIC MODEL TO INVESTIGATE PERICYTE-INDUCED STALLS. 1: University of Auckland, New Zealand; 2: University College London, England
12:48pm - 1:00pm
ID: 688 / 5.2: 5 AI-BASED GEOMETRIC AND HEMODYNAMIC BIOMARKERS FOR ABDOMINAL AORTIC ANEURYSM PREDICTION 1: ViTAA Medical Solutions Inc., Montréal, Québec, Canada; 2: Department of Biomedical Engineering, University of Calgary; 3: Department of Radiology, Harvard Medical School, Boston, Massachusetts, US; 4: Department of Vascular and Interventional Radiology, Centre Hospitalier de l'Université de Montréal, Québec, Canada; 5: Division of Vascular Surgery, AHN Allegheny General Hospital, Pittsburgh, Pennsylvania, US; 6: Division of Vascular Surgery, University of Washington, Seattle, Washington, US; 7: Division of Vascular Surgery, University of Calgary, Calgary, Alberta, Canada
| |||||